Yahoo Finance

PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator® Device for Non-Invasive Treatment of ALS

BOSTON, MA and PROVIDENCE, RI, Jan. 12, 2026 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for ...
Yahoo Finance

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms

Boston, MA and Providence, RI, Dec. 17, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for ...
manilatimes

PathMaker Neurosystems Announces Issuance of Three Patents Protecting the Use of Company's Proprietary Neuromodulation Technology in ALS

BOSTON, March 05, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker”), a clinical-stage neuromodulation company developing a breakthrough non-invasive treatment approach for amyotrophic ...